Global Animal-derived Immune Globulin Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Animal-derived Immune Globulin Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Immune globulin (Ig) short-term protection against hepatitis A and measles
Animal-derived Immune Globulin Products report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal-derived Immune Globulin Products market is projected to reach US$ 1726.3 million in 2029, increasing from US$ 1241 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Demand from Immunodeficiency and Autoimmune Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal-derived Immune Globulin Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Animal-derived Immune Globulin Products key manufacturers include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. Pfizer, Rare Disease Therapeutics, Bioclon Institute are top 3 players and held % sales share in total in 2022.
Animal-derived Immune Globulin Products can be divided into IVIg Liquid and IVIg Powder, etc. IVIg Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal-derived Immune Globulin Products is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Animal-derived Immune Globulin Products industry development. In 2022, global % sales of Animal-derived Immune Globulin Products went into Immunodeficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal-derived Immune Globulin Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type
IVIg Liquid
IVIg Powder
Immunodeficiency
Autoimmune Disease
Acute Infection
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal-derived Immune Globulin Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal-derived Immune Globulin Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal-derived Immune Globulin Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Animal-derived Immune Globulin Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal-derived Immune Globulin Products introduction, etc. Animal-derived Immune Globulin Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Animal-derived Immune Globulin Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Animal-derived Immune Globulin Products report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal-derived Immune Globulin Products market is projected to reach US$ 1726.3 million in 2029, increasing from US$ 1241 million in 2022, with the CAGR of 4.8% during the period of 2024 to 2029. Demand from Immunodeficiency and Autoimmune Disease are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal-derived Immune Globulin Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Animal-derived Immune Globulin Products key manufacturers include Pfizer, Rare Disease Therapeutics, Bioclon Institute, Merck & Co, Sanofi and BTG Specialty Pharmaceuticals, etc. Pfizer, Rare Disease Therapeutics, Bioclon Institute are top 3 players and held % sales share in total in 2022.
Animal-derived Immune Globulin Products can be divided into IVIg Liquid and IVIg Powder, etc. IVIg Liquid is the mainstream product in the market, accounting for % sales share globally in 2022.
Animal-derived Immune Globulin Products is widely used in various fields, such as Immunodeficiency, Autoimmune Disease and Acute Infection,, etc. Immunodeficiency provides greatest supports to the Animal-derived Immune Globulin Products industry development. In 2022, global % sales of Animal-derived Immune Globulin Products went into Immunodeficiency filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal-derived Immune Globulin Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Pfizer
Rare Disease Therapeutics
Bioclon Institute
Merck & Co
Sanofi
BTG Specialty Pharmaceuticals
Segment by Type
IVIg Liquid
IVIg Powder
Segment by Application
Immunodeficiency
Autoimmune Disease
Acute Infection
Segment by Region
North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal-derived Immune Globulin Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Animal-derived Immune Globulin Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Animal-derived Immune Globulin Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Animal-derived Immune Globulin Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Animal-derived Immune Globulin Products introduction, etc. Animal-derived Immune Globulin Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Animal-derived Immune Globulin Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices